KRONOX LAB SCIENCES LTD
KRONOX · General/Diversified · NSE
₹135
Current Market Price
Fair Value (DCF)
₹130
Discount to FV
-3.3%
Updated just now
YieldIQ Score
58/100
Piotroski F-Score
7/9
Economic Moat
Wide
Confidence
59%
ROE
23.8%
Debt/Equity
0.01
WACC
11.1%
Market Cap
₹499.31 Cr
Quality & Valuation
Neutral model outputs — no recommendations.
ROCE
33.5%
Return on capital employed
EV / EBITDA
14.0×
Enterprise multiple
Debt / EBITDA
0.0×
Leverage vs earnings
Interest Coverage
—
EBIT covers interest
Current Ratio
7.28×
Short-term liquidity
Asset Turnover
1.02×
Revenue per ₹ of assets
Revenue CAGR (3Y)
1.9%
3-year revenue growth
Revenue CAGR (5Y)
—
5-year revenue growth
DCF Scenario Analysis
vs CMP ₹134.57
Bear case
Discount -90.3%
Base case
Discount -3.4%
Bull case
Discount +13.8%
Ratio Trends
KRONOX · last 5 annual periods
ROE
23.8%
ROCE
33.5%
Operating Margin
—
Debt / Equity
0.01×
PE
—
EV / EBITDA
—
Historical Financials
KRONOX · Annual, last 5 years· amounts in ₹Cr unless noted
| Metric | 2022 yfinance | 2023 yfinance | 2024 NSE_XBRL | 2025 yfinance | 2026 yfinance | CAGR |
|---|---|---|---|---|---|---|
| Revenue | ₹82.2 Cr | ₹95.6 Cr | ₹89.9 Cr | ₹100 Cr | ₹101 Cr | +5.3% |
| EBITDA | ₹20.8 Cr | ₹23.9 Cr | ₹29.9 Cr | ₹35.7 Cr | ₹39.5 Cr | +17.4% |
| EBIT | — | — | ₹28.6 Cr | — | — | +0.0% |
| PAT | ₹13.6 Cr | ₹16.6 Cr | ₹21.4 Cr | ₹25.5 Cr | ₹27.7 Cr | +19.4% |
| EPS (diluted) | — | — | ₹5.81 | — | — | +0.0% |
| CFO | ₹9.0 Cr | ₹19.7 Cr | ₹17.4 Cr | ₹30.7 Cr | ₹23.9 Cr | +27.6% |
| CapEx | ₹-3.8 Cr | ₹-8.4 Cr | ₹-12.3 Cr | ₹-3.1 Cr | ₹-3.3 Cr | — |
| FCF | ₹5.2 Cr | ₹11.3 Cr | ₹5.1 Cr | ₹27.6 Cr | ₹20.6 Cr | +40.9% |
| Total Assets | ₹56.8 Cr | ₹54.0 Cr | ₹74.0 Cr | ₹98.8 Cr | ₹128 Cr | +22.4% |
| Total Debt | ₹3.4 Cr | ₹0.0 Cr | ₹0.0 Cr | — | ₹1.6 Cr | -16.8% |
| Shareholders' Equity | ₹40.4 Cr | ₹44.7 Cr | ₹66.3 Cr | ₹90.1 Cr | ₹116 Cr | +30.2% |
CAGR computed across the visible window. Signs reverse if start value is zero or negative.
Peer Comparison
KRONOX vs 5 closest peers by market-cap band
| Peer | MoS | Score | Verdict | ROE | PE |
|---|---|---|---|---|---|
DICIND DICIND | — | — | Pending | 4.1% | 25.6× |
ORIENTCER ORIENTCER | — | — | Pending | 3.5% | — |
 VINYLINDIA VINYLINDIA | — | — | Pending | 17.6% | — |
SHALPAINTS SHALPAINTS | — | — | Pending | -25.4% | — |
SUKHJITS SUKHJITS | — | — | Pending | 7.4% | — |
Click a ticker to view its fair-value analysis.
Dividend History
2 ex-dividend events on file. Source: NSE corporate-actions feed.
Total paid (5Y)
₹1.00/sh
Last payout
2025-08-08
₹0.50
Peak payout
₹0.50
Trailing yield
0.37%
Amounts parsed from NSE subject lines. Percent-of-face-value declarations are converted using the per-ticker face value (defaults to ₹10).
AI Analysis Summary
Model-generated description of metrics. Not investment advice. KRONOX LAB SCIENCES LTD (KRONOX.NS) trades at 134.57 vs a model fair value of 130.11, a gap of -3.3%. Piotroski F-score: 7/9. Moat label:...
Read full AI analysis →Reverse DCF
Market-implied growth
What FCF growth is priced in →
Risk Analysis
Volatility & drawdown
Risk profile of KRONOX →
DuPont
ROE decomposition
Why ROE is what it is →
Technicals
RSI, MACD, MAs
Reference indicators →
News & Filings
Recent activity
BSE filings + news for KRONOX →
Compare
Head-to-head with peers
Compare KRONOX side by side →
Run Full Interactive Analysis
Interactive DCF sliders, sensitivity heatmap, peer comparison, and more.
Analyse KRONOXNow →Model estimates using publicly available data. Not investment advice. YieldIQ is not registered with SEBI as an investment adviser or research analyst. Past performance does not guarantee future results.